The use of a urine lipoarabinomannan test in clinical decision-making regarding empiric tuberculosis treatment among HIV-positive patients suspected to have tuberculosis
Background. Tuberculosis (TB) is a major contributor to mortality among patients affected by HIV. TB diagnosis can be challenging, especially in those who are severely ill and unable to produce sputum. Urine lipoarabinomannan (LAM) is a rapid point‐of‐care diagnostic tool that is used on urine....
Saved in:
| Main Authors: | T R Makgoka, M de Villiers, D G Van Zyl |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
South African Medical Association
2025-02-01
|
| Series: | South African Medical Journal |
| Subjects: | |
| Online Access: | https://samajournals.co.za/index.php/samj/article/view/2143 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Test agreement between GeneXpert and urine lipoarabinomannan test for tuberculosis diagnosis among children in Ethiopia
by: Daniel Derese, et al.
Published: (2025-03-01) -
Blood and urine early treatment response biomarkers in HIV-associated disseminated tuberculosis
by: Linda Boloko, et al.
Published: (2025-04-01) -
Urine-based assays for inpatients with HIV-associated tuberculosis in rural South Africa
by: Mbulelo Mntonintshi, et al.
Published: (2025-06-01) -
Evaluating the expression level of serum Interleukin-2, lipoarabinomannan and circulating MicroRNA-29a as diagnostic biomarkers for pulmonary and extra-pulmonary tuberculosis: a pilot study
by: Subhamay Adhikary, et al.
Published: (2025-12-01) -
Value of urinary lipoarabinomannan levels for tuberculosis diagnosis and monitoring of therapy
by: Yiqun Xiong, et al.
Published: (2025-08-01)